Cambrex is a leading CDMO that provides comprehensive development and manufacturing solutions for small-molecule therapeutics.

Description

Cambrex is a leading global contract development and manufacturing organisation (CDMO) specialising in small molecule drug development and manufacturing.

Cambrex supports pharmaceutical innovators from development through commercialisation, offering a full spectrum of services for drug substance, drug product, and analytical testing. With facilities across North America and Europe, the company provides tailored solutions that emphasise scientific expertise, operational flexibility, and regulatory compliance.

Key Products and Services

  • Drug Substance Development and Manufacturing: Small molecule APIs, process development, and scale-up.
  • Drug Product Services: Oral solids, sterile injectables, and complex formulations.
  • Analytical Services: Method development, validation, and stability testing.
  • Specialised Capabilities: Controlled substances, high-potency APIs, and continuous flow processing.

With over 40 years of industry experience, Cambrex continues to drive innovation and excellence in pharmaceutical manufacturing, making it a trusted partner for pharmaceutical companies worldwide.

As a prominent player in the pharmaceutical industry, Cambrex continues to provide innovative solutions and manufacturing capabilities to its clients. For more information, please visit cambrex.com.
Certification
United States FDA, Canada Health Canada, Europe EMA, Denmark DKMA, India CDSCO, South Korea MFDS, UK MHRA, Sweden MPA, Brazil ANVISA, Italy AIFA

Manufacturing Information

Facilities
14
Drug Type
Small Molecule

Contact Information

Website
Twitter (X)
Address
One Meadowlands Plaza , 07073 , East Rutherford , NJ, United States
Zip/Post Code
7073
Facility Locations
United States, Germany, Estonia, Sweden, Italy, United Kingdom
Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.